CompaniesByCap
DMAC
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ · Healthcare

DiaMedica Therapeutics Inc. Cash Flow 2018–2018

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Operating Cash Flow-29.1M-22.1M-18.7M-11.5M-12.3M-9.2M-9.1M-5.7M-3.9M
Depreciation & Amort.
Investing Activities
Capital Expenditure40,00025,00024,00081,00022,00047,0002,00050,00022,000
Free Cash Flow-29.1M-22.1M-18.8M-11.6M-12.3M-9.2M-9.1M-5.7M-3.9M
Financing Activities
Dividends Paid
Stock Buybacks

DiaMedica Therapeutics Inc. Cash Flow — FAQ

DiaMedica Therapeutics Inc. (DMAC) cash flow over the last 1 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DMAC's cash flow history?

The chart and table above show DiaMedica Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.